CMEA Ventures VII LP

This profile gathers the share dealings of CMEA Ventures VII LP across 2 companies, led by Auspex Pharmaceuticals, Inc. and Ardelyx, Inc. We count 109 filings; the first trade dates from 10 February 2014 and the latest from 8 April 2015.

The open-market side counts 4 purchases for €4.2M alongside 81 sales for €42.8M. The net balance comes to €38.6M on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 10 share grants. In 2015 alone, the filings show no purchases and 27 sales.

In size, the median ticket on the buying side is €494k.

The newest entry dates from 10 April 2015: a transaction, in Ardelyx, Inc. The last purchase on record was published on 26 June 2014, which is 4,503 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.